The efficacy of oral beta-carotene for the prevention of photosensitivity symptoms in erythropoietic protoporphyria was studied in a controlled cross-over trial in which it was compared with a placebo. No significant difference was found between the 2 preparations. Patients' symptoms showed statistically significant association with sunlight hour records.

DOI: 10.1111/j.1365-2133.1977.tb14273.x
Version: za2963e q8zaa q8zb0 q8zc0 q8zd1 q8zea q8zf2 q8zge